U.S. flag

An official website of the United States government

NM_000212.3(ITGB3):c.740G>A (p.Gly247Asp) AND Glanzmann thrombasthenia 2

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Mar 1, 2010
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000014537.31

Allele description [Variation Report for NM_000212.3(ITGB3):c.740G>A (p.Gly247Asp)]

NM_000212.3(ITGB3):c.740G>A (p.Gly247Asp)

Gene:
ITGB3:integrin subunit beta 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
17q21.32
Genomic location:
Preferred name:
NM_000212.3(ITGB3):c.740G>A (p.Gly247Asp)
Other names:
G221D
HGVS:
  • NC_000017.11:g.47286385G>A
  • NG_008332.2:g.37544G>A
  • NM_000212.3:c.740G>AMANE SELECT
  • NP_000203.2:p.Gly247Asp
  • LRG_481:g.37544G>A
  • NC_000017.10:g.45363751G>A
  • NM_000212.2(ITGB3):c.740G>A
  • P05106:p.Gly247Asp
Protein change:
G247D; GLY221ASP
Links:
UniProtKB: P05106#VAR_069922; OMIM: 173470.0017; dbSNP: rs79560904
NCBI 1000 Genomes Browser:
rs79560904
Molecular consequence:
  • NM_000212.3:c.740G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Glanzmann thrombasthenia 2
Synonyms:
BLEEDING DISORDER, PLATELET-TYPE, 23
Identifiers:
MONDO: MONDO:0031009; MedGen: C5543273; OMIM: 619267

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000034788OMIM
no assertion criteria provided
Pathogenic
(Mar 1, 2010)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

AlphaIIbbeta3 integrin: new allelic variants in Glanzmann thrombasthenia, effects on ITGA2B and ITGB3 mRNA splicing, expression, and structure-function.

Jallu V, Dusseaux M, Panzer S, Torchet MF, Hezard N, Goudemand J, de Brevern AG, Kaplan C.

Hum Mutat. 2010 Mar;31(3):237-46. doi: 10.1002/humu.21179.

PubMed [citation]
PMID:
20020534

Details of each submission

From OMIM, SCV000034788.7

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In a patient with Glanzmann thrombasthenia (GT2; 619267), Jallu et al. (2010) identified compound heterozygosity for 2 mutations in the ITGB3 gene: a 740G-A transition in exon 5, resulting in a gly221-to-asp (G221D) substitution in the mature protein, and K253M (173470.0016). Both mutations are located in the beta-I domain. Flow cytometric studies of the mutant protein expressed in COS-7 cells showed that the mutation prevented normal GPIIb/IIIa complex expression on the cell surface consistent with a severe type 1 phenotype. However, specific antibodies detected some residual expression of the IIIa protein. Jallu et al. (2010) postulated that the mutation interferes with correct folding of the protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Oct 13, 2024